The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of bevacizumab on the occurrence and recurrence of intracranial brain metastases in non-small cell lung cancer (NSCLC) patients.
Mohamed E. Salem
No relevant relationships to disclose
Nicholas Szerlip
No relevant relationships to disclose
Nathan A. Pennell
Consultant or Advisory Role - Boehringer Ingelheim; Oncogenex
Research Funding - Genentech
Khaled B. Ali
No relevant relationships to disclose
David Altshuler
No relevant relationships to disclose
Stephanie Taylor
No relevant relationships to disclose
Abhirami Hallock
No relevant relationships to disclose
Ammar Sukari
No relevant relationships to disclose
Shirish M. Gadgeel
No relevant relationships to disclose
Antoinette J. Wozniak
No relevant relationships to disclose